Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Price indices track market movements to gauge overall levels. This intro explains what a price index is and why it matters for investors and analysts.
21,879 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
In uncertain markets, the best consumer staples stocks stand out for their steady demand and reliable dividends. Lear...
A senior Rogers Corp. executive sold 830 shares for about $113,000, sparking questions about what it means for the st...
Nvidia sits at the center of AI, and May 20 earnings looms large. This guide breaks down whether you should Nvidia st...
Great Elm's Q3 2026 earnings shed light on growth, margins, and capital allocation. This article breaks down the numb...
Google’s Gemini AI released a bold Solana forecast, pairing a performance upgrade roadmap with a price trajectory tha...
As AI demand accelerates, Nvidia stands out on a growth-adjusted valuation. Cramer argues the stock is cheaper than p...
In a market where dividends among healthcare firms can be elusive, two names stand out for investors seeking income n...
Canopy Growth has slipped while the market rose. This article breaks down the reasons behind the drop, what it means ...
When a CFO sells shares after exercising options, investors want the real story. This article explains what ambiq mic...
When markets wobble, fear can block smart moves. This guide walks you through a calm, practical approach to a market ...
CME Group is launching 24/7 Bitcoin futures and options, eliminating weekend gap signals and expanding around-the-clo...